Raphael Schiffmann
8PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Aug 02, 2025
ARSA Variants Associated With Cognitive Decline and Long-Term Preservation of Motor Function in Metachromatic Leukodystrophy.Shanice Beerepoot, Daphne H Schoenmakers, Francesca Fumagalli
|May 27, 2024
Qualitative Study of the Patient Experience with Venglustat for Gaucher Disease Type 3 in a Phase 2 Open-Label, Multicenter, Multinational Study (LEAP).Raphael Schiffmann, Eugen Mengel, Mary Wallace
|Nov 06, 2023
Comparison of efficacy between subcutaneous and intravenous application of moss-aGal in the mouse model of Fabry disease.Paulina Dabrowska-Schlepp, Andreas Busch, Jin-Song Shen
|Oct 18, 2022
Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial.Raphael Schiffmann, Timothy M Cox, Jean-François Dedieu
|Sep 30, 2020
Assessment of plasma lyso-Gb<sub>3</sub> for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease.Daniel G Bichet, Johannes M Aerts, Christiane Auray-Blais
|Apr 04, 2020
The definition of neuronopathic Gaucher disease.Raphael Schiffmann, Jeff Sevigny, Arndt Rolfs
Pageof 2
Frequent Collaborators
2 joint publications
Odile Boespflug-Tanguy
2 joint publications
Fanny Mochel
2 joint publications
Eugen Mengel
1 joint publications
L Saint-Val
1 joint publications
T Courtin
1 joint publications
P Charles
1 joint publications
C Verny
1 joint publications
M Catala
1 joint publications
Timothy M Cox
1 joint publications
Paulina Dabrowska-Schlepp
